United States · Series A startup

Who invested in twoXAR

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$10Mraised across 1 round since 2018, from 1 source

Latest round
Series A, $10MMar 2018
Investors
2
See who backed them

The rounds

  1. Mar 2018
    Series A$10M
    • OS Fund
    • SoftBank Ventures/ Andreessen Horowitz Bio Fund

    Reported by FinSMEs

Founders and team

From the SEC filings it signed: 3 on the team.

  • Andrew RadinPresident, Treasurer, Secretary and Sole Directori
  • Leor S PantilatAssistant Secretaryi
  • Ted S HollifieldAssistant Secretaryi

Everyone who backed them

OS FundVC firm1round
SoftBank Ventures/ Andreessen Horowitz Bio Fundno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists twoXAR as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

CLI VenturesVC firmPer its own site

Quick answers about twoXAR

Who invested in twoXAR?

twoXAR's investors include OS Fund and SoftBank Ventures/ Andreessen Horowitz Bio Fund.

How much has twoXAR raised?

twoXAR has raised $10M across 1 round since 2018.

When did twoXAR last raise?

twoXAR's most recent round was a Series A of $10M in Mar 2018.

What was twoXAR's biggest round?

Its most recent round, $10M in Mar 2018, is also its largest on record.

Who backed twoXAR first?

twoXAR's first round on record, in Mar 2018, was backed by OS Fund and SoftBank Ventures/ Andreessen Horowitz Bio Fund.

What stage is twoXAR at?

twoXAR's latest named round is a Series A, in Mar 2018.

Where is twoXAR based?

twoXAR is based in the United States.

Companies like twoXAR

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.